-
Figure 1. Left, stepwise schematic of the pathogenesis of IgAN. Adjacent to each step are listed relevant opportunities for diagnosis or therapy. RAAS, renin-angiotensin aldosterone system.
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1
Mestecky J , et al.. IgA nephropathy: molecular mechanisms of the disease. Annu Rev Pathol 2013; 8:217−240.
-
2
Suzuki Y , et al.. Serum levels of galactose-deficient immunoglobulin (Ig) A1 and related immune complex are associated with disease activity of IgA nephropathy. Clin Exp Nephrol 2014 Jan 30 [Epub ahead of print].
-
3
Cattran DC , et al.. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 2009; 76:534−545.
-
4
Coppo R , et al.. Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments. Kidney Int 2014 Apr 2 [Epub ahead of print].
-
5
Kiryluk K , et al.. Pathogenesis of immunoglobulin A nephropathy: recent insight from genetic studies. Annu Rev Med 2013; 64:339−356.
-
6
Kiryluk K , et al.. Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis. PLoS Genet 2012; 8:e1002765.
Progress in IgA Nephropathy and Its Clinical Implications
Pietro A. Canetta
Pietro A. Canetta
Pietro A. Canetta, MD, is assistant professor of medicine, division of nephrology, Columbia University College of Physicians and Surgeons, New York;
Search for other papers by Pietro A. Canetta in
Current site
Google Scholar
PubMed
Search for other papers by Pietro A. Canetta in
Current site
Google Scholar
PubMed
© 2021 American Society of Nephrology | All Rights Reserved
Powered by: PubFactory
Powered by PubFactory